# Involvement of Reticulum Endoplasmic Stress in the Physiopathology of Polycystic Ovary Syndrome

> **NCT02302326** · NA · COMPLETED · sponsor: **Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana** · enrollment: 50 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Metformin
- **DIETARY_SUPPLEMENT:** Myo-inositol + folic acid

## Key facts

- **NCT ID:** NCT02302326
- **Lead sponsor:** Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02302326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02302326, "Involvement of Reticulum Endoplasmic Stress in the Physiopathology of Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02302326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*